Showing 101 - 120 results of 175 for search '"PCOS"', query time: 0.07s Refine Results
  1. 101

    Identification of molecular characteristics in polycystic ovary syndrome using single-cell and transcriptome analysis by Xiaolin Zhu, Yanhua Han, Yuenan Feng, Yuanli Shan, Chang Liu, Kexin Wang, Xiaoke Li, Shidi Zhang, Yaguang Han

    Published 2025-01-01
    “…Abstract Polycystic Ovary Syndrome (PCOS) is a complex endocrine disorder affecting women of childbearing age, and we aimed to reveal its underlying molecular mechanisms. …”
    Get full text
    Article
  2. 102

    Leptin as well as Free Leptin Receptor Is Associated with Polycystic Ovary Syndrome in Young Women by Nasser M. Rizk, Elham Sharif

    Published 2015-01-01
    “…The aim of this study is to assess the concentrations of the leptin and the sOB-R in PCOS and its relation to adiposity, insulin resistance, and androgens. …”
    Get full text
    Article
  3. 103
  4. 104

    Risk of Type 2 Diabetes Mellitus following Gestational Diabetes Pregnancy in Women with Polycystic Ovary Syndrome by Joan C. Lo, Jingrong Yang, Erica P. Gunderson, Mohammad K. Hararah, Joel R. Gonzalez, Assiamira Ferrara

    Published 2017-01-01
    “…This study examines gestational diabetes mellitus (GDM) in women with polycystic ovary syndrome (PCOS) and the risk of type 2 diabetes mellitus (DM) following GDM pregnancy. …”
    Get full text
    Article
  5. 105

    Plasma Asprosin Levels Are Associated with Glucose Metabolism, Lipid, and Sex Hormone Profiles in Females with Metabolic-Related Diseases by Xing Li, Mingyu Liao, Rufei Shen, Linlin Zhang, Hua Hu, Jun Wu, Xiuli Wang, Hua Qu, Shaodong Guo, Min Long, Hongting Zheng

    Published 2018-01-01
    “…However, the role of asprosin in polycystic ovary syndrome (PCOS), a disease partly characterized by insulin resistance, and its potential connection with type 2 diabetes mellitus (T2DM) and PCOS has not been thoroughly elucidated to date. …”
    Get full text
    Article
  6. 106

    The role of immunity in insulin resistance in patients with polycystic ovary syndrome by Qixuan Zhang, Zhe Yang, Xiangyang Ou, Mengying Zhang, Xiangyu Qin, Gengxiang Wu

    Published 2025-01-01
    “…While the precise pathogenesis of PCOS remains unclear, it is now recognized that genetic, endocrine, and metabolic dysregulations all contribute significantly to its onset. …”
    Get full text
    Article
  7. 107
  8. 108

    Effect of “DXB-2030,” a Polyherbal Formulation, on Experimental Polycystic Ovary Syndrome Associated with Hyperandrogenism by Mohammed Azeemuddin, Suryakanth D. Anturlikar, Mallappa Onkaramurthy, Mirza R. Baig, Basti K. Ashok, Raghavendra P. Rao, Mohamed Rafiq, Paramesh Rangesh

    Published 2019-01-01
    “…From the results obtained, it can be concluded that “DXB-2030” was effective in the management of experimental PCOS and hence may be recommended in the treatment of PCOS.…”
    Get full text
    Article
  9. 109

    Comparison Of Glucagon Like Peptide/1 Levels In Diabetic Women With Ovarian Polycystic Syndrome And Healthy Women by Namra Iqtidar, Imran Ali Zaidi, Sobia Niaz, Javaria Latif, Amir Naveed, Ayesha Yousaf

    Published 2024-09-01
    “…Conclusion: The study shows low GLP-1 levels are seen in PCOS with DM as compared to healthy women. …”
    Get full text
    Article
  10. 110

    Prevalence and factors associated with non-alcoholic fatty liver disease among women with polycystic ovary syndrome by Maria Elisa Franciscatto, Juliana Bosso Taniguchi, Raquel Wohlenberg, Isadora Luísa Riedi, Karen Oppermann

    Published 2025-01-01
    “…Abstract Objective: To verify the prevalence and factors associated with Non-Alcoholic Fatty Liver Disease (NAFLD) among women with Polycystic Ovary Syndrome (PCOS). Methods: A cross-sectional study was conducted with 53 patients with PCOS. …”
    Get full text
    Article
  11. 111

    Evaluation of Retinal Changes in Women with Different Phenotypes of Polycystic Ovary Syndrome by Fatma Sumer, Beril Gurlek, Elif Yildiz, Feyzahan Uzun, Sabri Colak, Ilknur Merve Ayazoglu

    Published 2025-01-01
    “…<b>Materials and Methods</b>: This prospective case–control study included 120 eyes of 120 women with PCOS, with each of the four distinct phenotypes comprising 30 eyes of 30 women. …”
    Get full text
    Article
  12. 112
  13. 113

    SLC6A4 5HTTLPR Polymorphism Affects Insulin Secretion in Patients with Polycystic Ovary Syndrome by Barbara Šenk, Katja Goričar, Nika Aleksandra Kravos, Mojca Jensterle Sever, Andrej Janež, Vita Dolžan

    Published 2018-01-01
    “…To investigate in a pilot study of genetic polymorphisms in serotonin system influencing basal- and glucose-stimulated insulin secretion in women with polycystic ovary syndrome (PCOS). Methods. A cross-sectional study included 65 female patients with PCOS followed up at the endocrine outpatient clinic of the University Medical Center Ljubljana and a control group of 94 young healthy female blood donors. …”
    Get full text
    Article
  14. 114

    Prevalence Of Skin Manifestations In Patients With Polycystic Ovarian Syndrome by Tehseen Naveed, Asma Afzal Kiyani, Sameena Kausar, Aqsa Naheed, Dawood Khan, Sakina Sadiq Malik

    Published 2024-03-01
    “…Keywords: PCOS, Skin manifestations, Hyperandrogenism, Hirsutism, Acne. …”
    Get full text
    Article
  15. 115

    Evaluating the effects of time-restricted eating on overweight and obese women with polycystic ovary syndrome: A randomized controlled trial study protocol. by Hui Liu, Fuliang Shangguan, Fen Liu, Yu Guo, Huixi Yu, Hanbing Li, Yinhua Su, Zhongyu Li

    Published 2025-01-01
    “…<h4>Discussion</h4>The purpose of this study protocol is to further evaluate the effects of TRE in overweight and obese women with PCOS through a randomized controlled trial (RCT). …”
    Get full text
    Article
  16. 116

    Correlation of Endometrial Glycodelin Expression and Pregnancy Outcome in Cases with Polycystic Ovary Syndrome Treated with Clomiphene Citrate Plus Metformin: A Controlled Study by Selda Uysal, Ahmet Zeki Isik, Serenat Eris, Seyran Yigit, Yakup Yalcin, Pelin Ozun Ozbay

    Published 2015-01-01
    “…A total of 30 patients diagnosed with polycystic ovary syndrome (PCOS) according to the Rotterdam criteria constituted our study group. …”
    Get full text
    Article
  17. 117

    Prediction of Insulin Resistance and Impaired Fasting Glucose Based on Sex Hormone-Binding Globulin (SHBG) Levels in Polycystic Ovary Syndrome by Aleksandra Biernacka-Bartnik, Piotr Kocełak, Aleksander Jerzy Owczarek, Piotr Choręza, Monika Puzianowska-Kuźnicka, Leszek Markuszewski, Paweł Madej, Jerzy Chudek, Magdalena Olszanecka-Glinianowicz

    Published 2022-01-01
    “…Therefore, this study aimed to assess the prediction of IR and impaired fasting glucose (IFG) based on SHBG levels in women with PCOS. Methods. This analysis included data retrieved from medical records of 854 patients with PCOS hospitalized in the Gynecological Endocrinology Clinic from 2012 to 2019. …”
    Get full text
    Article
  18. 118

    Patient-centered outcomes for gastrointestinal cancer care: a scoping review protocol by Natalie G Coburn, Frances C Wright, Alyson L Mahar, Lesley Gotlib Conn, Julie Hallet, Amy T Hsu, Paul D James, Joanna Yang, Tori Barabash, Luckshi Rajendran, Claire Ludwig, Ekaterina Kosyachkova, Julie Deleemans

    Published 2022-06-01
    “…This scoping review will summarise the existing literature on PCOs in gastrointestinal (GI) cancer care as well as the tools used to assess these outcomes. …”
    Get full text
    Article
  19. 119

    MicroRNA-223 Expression Is Upregulated in Insulin Resistant Human Adipose Tissue by Tung-Yueh Chuang, Hsiao-Li Wu, Chen-Chun Chen, Gloria Mabel Gamboa, Lawrence C. Layman, Michael P. Diamond, Ricardo Azziz, Yen-Hao Chen

    Published 2015-01-01
    “…We previously reported that adipose tissue (AT) from women with polycystic ovary syndrome (PCOS) or controls with insulin resistance (IR) revealed a differentially expressed microRNA (miRNA) profile, including upregulated miR-93 in PCOS patients and in non-PCOS women with IR. …”
    Get full text
    Article
  20. 120